Using Support Vector Machine (SVM) for Classification of Selectivity of H1N1 Neuraminidase Inhibitors

被引:22
作者
Li, Yang [1 ]
Kong, Yue [1 ]
Zhang, Mengdi [1 ]
Yan, Aixia [1 ,2 ]
Liu, Zhenming [2 ]
机构
[1] Beijing Univ Chem Technol, Dept Pharmaceut Engn, State Key Lab Chem Resource Engn, POB 53,15 BeiSanHuan East Rd, Beijing 100029, Peoples R China
[2] Peking Univ, Stake Key Lab Nat & Biomimet Drugs, Beijing, Peoples R China
基金
中国国家自然科学基金;
关键词
Neuraminidase inhibitors (NAIs); Classification models; Support vector machine (SVM); MASSC fingerprints; Extended connectivity fingerprints (ECFP_4); INFLUENZA-VIRUS NEURAMINIDASE; POTENT INHIBITORS; AVIAN INFLUENZA; DRUG DISCOVERY; QSAR; DERIVATIVES; SOLUBILITY; RESISTANCE; DOCKING; ANALOGS;
D O I
10.1002/minf.201500107
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Inhibition of the neuraminidase is one of the most promising strategies for preventing influenza virus spreading. 479 neuraminidase inhibitors are collected for dataset 1 and 208 neuraminidase inhibitors for A/P/8/34 are collected for dataset 2. Using support vector machine (SVM), four computational models were built to predict whether a compound is an active or weakly active inhibitor of neuraminidase. Each compound is represented by MASSC fingerprints and ADRIANA. Code descriptors. The predication accuracies for the test sets of all the models are over 78%. Model 2B, which is the best model, obtains a prediction accuracy and a Matthews Correlation Coefficient (MCC) of 89.71% and 0.81 on test set, respectively. The molecular polarizability, molecular shape, molecular size and hydrogen bonding are related to the activities of neuraminidase inhibitors. The models can be obtained from the authors.
引用
收藏
页码:116 / 124
页数:9
相关论文
共 54 条
[1]  
[Anonymous], MACCS KEYS
[2]  
[Anonymous], 2012, MOE VERS 2008 10
[3]  
Chang C.-C., LIBSVM: a Library for Support Vector Machines
[4]   STRUCTURE OF THE CATALYTIC AND ANTIGENIC SITES IN INFLUENZA-VIRUS NEURAMINIDASE [J].
COLMAN, PM ;
VARGHESE, JN ;
LAVER, WG .
NATURE, 1983, 303 (5912) :41-44
[5]   INFLUENZA-VIRUS NEURAMINIDASE - STRUCTURE, ANTIBODIES, AND INHIBITORS [J].
COLMAN, PM .
PROTEIN SCIENCE, 1994, 3 (10) :1687-1696
[6]   Quantitative structure-activity relationship study of influenza virus neuraminidase A/PR/8/34 (H1N1) inhibitors by genetic algorithm feature selection and support vector regression [J].
Cong, Yong ;
Li, Bing-ke ;
Yang, Xue-gang ;
Xue, Ying ;
Chen, Yu-zong ;
Zeng, Yi .
CHEMOMETRICS AND INTELLIGENT LABORATORY SYSTEMS, 2013, 127 :35-42
[7]   Chalcones as novel influenza A (H1N1) neuraminidase inhibitors from Glycyrrhiza inflata [J].
Dao, Trong Tuan ;
Nguyen, Phi Hung ;
Lee, Hong Sik ;
Kim, Eunhee ;
Park, Junsoo ;
Lim, Seong Il ;
Oh, Won Keun .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (01) :294-298
[8]   3D QSAR and docking study of flavone derivatives as potent inhibitors of influenza H1N1 virus neuraminidase [J].
Gao, Li ;
Zu, Mian ;
Wu, Song ;
Liu, Ai-Lin ;
Du, Guan-Hua .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (19) :5964-5970
[10]   Support vector machines for drug discovery [J].
Heikamp, Kathrin ;
Bajorath, Juergen .
EXPERT OPINION ON DRUG DISCOVERY, 2014, 9 (01) :93-104